The United States represents the world's largest pharma market. In last few years, the pharma market growth has slowed down because of patent expirations of key blockbusters drugs and the introduction of cheaper generics. But with the proposed healthcare reform which is aimed to regulate spending, the pharma market will regain its growth rate in the next few years, According to our new research study "US Healthcare Sector Forecast to 2012", the US pharma market is forecasted to grow at a CAGR of around 3% during 2010-2012.
Identifying increased healthcare spending as the key reason for growth, our research experts have said that the healthcare spending has become more unregulated and a major part of it is spent on the administration process. Besides, the prevalence of lifestyle diseases has substantially increased, forcing people to spend more on healthcare checkup. In this regard, our research offers a comprehensive statistical analysis of healthcare spending.
In addition, our research experts have also studied the progress of healthcare infrastructure development and found that there is a high demand for hospital services in the US. Our analysts have found that the rural areas lag behind the urban area in terms of healthcare services penetration, which clearly points that the huge potential exists for future market growth. We believe that regulatory environment plays an important role in the development of healthcare industry and our report provides complete information of regulatory environment in the US.
"US Healthcare Sector Forecast to 2012" provides extensive research and unbiased analysis of the US healthcare sector and its various segments such as medical device market and healthcare insurance market. The report contains data for the number of hospital beds required in near term in order to meet growing demand for hospital services. Besides, it tells about the number of inpatients, outpatients, sales of generic and branded drugs, and export and import of medical equipments. The report also includes key players along with their business expertise which can be useful for investors while investing.
For more information visit: http://www.rncos.com/Report/IM231.htm |
